These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 1336840

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients.
    Lacroix JS, Mosimann BL.
    J Allergy Clin Immunol; 1996 Sep; 98(3):611-6. PubMed ID: 8828539
    [Abstract] [Full Text] [Related]

  • 8. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S, Holzhausen HJ, Riederer A, Bloching M.
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
    Graf P, Juto JE.
    ORL J Otorhinolaryngol Relat Spec; 1994 Oct; 56(3):157-60. PubMed ID: 7515487
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits.
    Suh SH, Chon KM, Min YG, Jeong CH, Hong SH.
    Acta Otolaryngol; 1995 Sep; 115(5):664-71. PubMed ID: 8928640
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity.
    Graf P, Hallén H, Juto JE.
    Acta Otolaryngol; 1995 Jan; 115(1):71-5. PubMed ID: 7762389
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2.
    Wagenmann M, Baroody FM, Desrosiers M, Hubbard WC, Ford S, Lichtenstein LM, Naclerio RM.
    Clin Exp Allergy; 1996 Apr; 26(4):371-8. PubMed ID: 8732233
    [Abstract] [Full Text] [Related]

  • 17. Neuropeptide Y is a vasoconstrictor in human nasal mucosa.
    Baraniuk JN, Silver PB, Kaliner MA, Barnes PJ.
    J Appl Physiol (1985); 1992 Nov; 73(5):1867-72. PubMed ID: 1282125
    [Abstract] [Full Text] [Related]

  • 18. Late phase response during nasal challenge: effect of astemizole on leukotriene B4 levels.
    Kumar NS, Schaefer PA, Lark G, Frieri M.
    Allergy Asthma Proc; 1996 Nov; 17(2):93-9. PubMed ID: 8934801
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.